2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: Impulse Control Disorders in a Brazilian population with Parkinson´s disease -an observational study

B. Veiga, V. Borges, H. Ferraz, C. Aquino, C. Giacominelli, SM. Silva, S. Lestingi (São Paulo, Brazil)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: In vivo increased striatal iron deposition in Parkinson’s Disease Dementia and Dementia with Lewy Body

S. Rota, T. Yousaf, H. Wilson, G. Dervenoulas, G. Pagano, D. Aarsland, M. Politis (London, United Kingdom)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Incidental iron deposition in basal ganglia: does the pattern matter? Fifteen years’ experience in a tertiary care center.

á. Beltrán Corbellini, P. Pérez Torre, A. Alonso Cánovas, F. Rodríguez Jorge, JL. Chico García, P. Parra Díaz, E. Natera Villalba, A. Gómez López, S. Fanjul Arbos, JL. López Sendón, JC. Martínez Castrillo, I. Parées Moreno (Madrid, Spain)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Increased fractional anisotropy in precuneus in Parkinson’s disease without mild cognitive impairment – a diffusion tensor imaging study

A. Nagano-Saito, J. Houde, C. Bedetti, M. Côté, O. Monchi (Montreal, QC, Canada)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Increased hub function in posterior medial cortex in Parkinson’s disease without mild cognitive impairement – A resting state fMRI study –

A. Nagano-Saito, P. Bellec, S. Jobert, B. Mejia-Constain, C. Degroot, A. Lafontaine, A. Hanganu, J. Lissemore, K. Smart, C. Benkelfat, O. Monchi (Montreal, QC, Canada)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Inflammatory Conditions in Parkinson’s Disease

B. Krishnamachari, S. Shermon, M. Goldfinger, A. Leder, B. Harper, J. Donoghue (Old Westbury, NY, USA)

Epidemiology · Les Muses, Level 3

1:15pm-2:45pm: Influence of cognitive abilities on prominence production in mild dysarthric patients with Parkinson’s disease

T. Thies, D. Mücke, A. Lowit, J. Steffen, E. Kalbe, M. Barbe (Cologne, Germany)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Influence of Cognitive Deficits and Tremor Severity of the Development of Depression in Nondemented Patients with Essential Tremor

M. Petrova, O. Grigorova, M. Raycheva, L. Traykov (Sofia, Bulgaria)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Influence of controlled-release levodopa on quality of sleep and nocturnal movements

E. Schaeffer, L. Zaunbrecher, I. Liepelt-Scarfone, C. Hansen, W. Maetzler, S. Nussbaum, B. Roeben, M. Elshehabi, P. Saraykin, S. Otterbein, J. Busch, D. Berg (Kiel, Germany)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Initial programming in STN-DBS for Parkinson’s disease: Standard vs. Steered Stimulation

R. Maciel, D. Soh, R. Munhoz, Y. Poon, S. Kalia, M. Hodaie, A. Lozano, A. Fasano (Toronto, ON, Canada)

Surgical Therapy · Les Muses Terrace, Level 3